0 Comentários
0 Compartilhamentos
158 Visualizações
0 Anterior
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça Login para curtir, compartilhar e comentar!
-
Global Therapeutic Monoclonal Antibodies Market Set to Reach USD 415.5 Billion by 2032, Growing at 11.0% CAGRGlobal therapeutic monoclonal antibodies drug market size was valued at USD 175.3 billion in 2024. The market is projected to grow from USD 195.1 billion in 2025 to USD 415.5 billion by 2032, exhibiting a CAGR of 11.0% during the forecast period. Therapeutic monoclonal antibodies (mAbs) are laboratory-engineered proteins designed to bind to specific targets, such as cancer cells or inflammatory...0 Comentários 0 Compartilhamentos 283 Visualizações 0 Anterior
-
How Monoclonal Antibodies and Vaccines Are Shaping the Product LandscapeThe GCC Downstream Processing market is expanding as biopharmaceutical manufacturers invest in advanced purification and separation technologies to address the rising incidence of chronic diseases and improve patient outcomes. The market was valued at USD 2.5 billion in 2024 and is projected to reach USD 5.0 billion by 2035, growing at a CAGR of 7.2%. The GCC Downstream Processing Market...0 Comentários 0 Compartilhamentos 25 Visualizações 0 Anterior
-
Recombinant Protein Therapeutics and Monoclonal Antibodies: Building a Comprehensive Biopharmaceutical Framework in ChinaThe management of serious diseases requires a sophisticated approach that combines advanced biologic therapies with personalized treatment strategies. At the core of this approach are Recombinant Protein Therapeutics and Monoclonal Antibodies , which work together to provide comprehensive treatment options for patients with cancer, autoimmune diseases, and other conditions....0 Comentários 0 Compartilhamentos 507 Visualizações 0 Anterior
-
CHST15 Antibody Market Growth Factors and Emerging TechnologiesThe global CHST15 antibody market is gaining significant momentum due to the increasing focus on cancer research, molecular diagnostics, and targeted therapeutic development. CHST15 antibodies are widely utilized in biomedical research to study carbohydrate sulfotransferase 15 expression and its role in tumor progression, fibrosis, and inflammatory diseases. Growing investments in biotechnology...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Comentários 0 Compartilhamentos 2K Visualizações 0 Anterior
-
Lymphoma Treatment Market Growth Potential Driven by Advances in Cancer TherapeuticsThe lymphoma treatment market is witnessing significant growth as healthcare providers increasingly focus on improving outcomes for patients diagnosed with Hodgkin lymphoma and non-Hodgkin lymphoma. Rising cancer prevalence, advancements in oncology research, and the growing adoption of innovative treatment approaches are contributing to the expansion of the market. The development of targeted...0 Comentários 0 Compartilhamentos 1K Visualizações 0 Anterior
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek